Evidence map›Paper›PMID 35477524›Full record

ArticleBMJ (Clinical research ed.)2022

Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis.

Sarah E Hughes, Shamil Haroon, Anuradhaa Subramanian, Christel McMullan, Olalekan L Aiyegbusi, Grace M Turner, Louise Jackson, Elin Haf Davies, Chris Frost, Gary McNamara and 6 more

3 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 75 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 3 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06253806 phase2completednot on this mapstarted 2023, after this paper: background citation

Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: Double-Blinded, Placebo-Controlled Randomized Clinical Trial

TypeinterventionalSponsorWashington University School of MedicineRan2023 to 2024Enrolled48ConditionsCOVID-19-Induced ParosmiaArmsStellate Ganglion Block, Placebo Sham Injection
NCT06883513 narecruitingnot on this mapstarted 2025, after this paper: background citation

Osteopathic Manipulative Therapy(OMT) Effects on Post-Acute Sequalae of COVID-19(PASC)

TypeinterventionalSponsorUniversity of LouisvilleRan2025 to 2025Enrolled20ConditionsLong-COVID, PASC, Long COVID SyndromeArmsOsteopathic Manipulative Therapy Long-COVID protocol, Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol
NCT06940609 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation (MANIFEST)

TypeinterventionalSponsorUniversity of New MexicoRan2025 to 2029Enrolled60ConditionsLong COVID, Long COVID Syndrome, Long COVID-19 Syndrome, PASCArmsaccelerated intermittent theta burst stimulation
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 3 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review.International journal of environmental research and public health · 2023
    Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Sarah E HughesCentre for Patient Reported Outcome Research, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK s.e.hughes@bham.ac.uk.ORCID 0000-0001-5656-1198
Shamil HaroonInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Anuradhaa SubramanianInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Christel McMullanCentre for Patient Reported Outcome Research, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
Olalekan L AiyegbusiCentre for Patient Reported Outcome Research, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
Grace M TurnerCentre for Patient Reported Outcome Research, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
Louise JacksonInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Elin Haf DaviesAparito, Wrexham, UK.
Chris FrostAparito, Wrexham, UK.
Gary McNamaraAparito, Wrexham, UK.
Gary PriceCentre for Patient Reported Outcome Research, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
Karen MatthewsLongCOVIDSOS, Faringdon, UK.
Jennifer CamaradouTherapies for Long COVID (TLC) Study, University of Birmingham, Birmingham, UK.
Jane OrmerodLong COVID Scotland, Edinburgh, UK.
Anita WalkerCentre for Patient Reported Outcome Research, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
Melanie J CalvertCentre for Patient Reported Outcome Research, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
University of Birmingham · GBNIHR Surgical Reconstruction and Microbiology Research Centre · GBMcMaster University · CA

Funding

Medical Research Council MC_PC_20050
6 · The paper itself

Abstract

objectiveTo describe the development and validation of a novel patient reported outcome measure for symptom burden from long covid, the symptom burden questionnaire for long covid (SBQ-LC).

designMultiphase, prospective mixed methods study.

settingRemote data collection and social media channels in the United Kingdom, 14 April to 1 August 2021.

participants13 adults (aged ≥18 years) with self-reported long covid and 10 clinicians evaluated content validity. 274 adults with long covid field tested the draft questionnaire.

main outcome measuresPublished systematic reviews informed development of SBQ-LC's conceptual framework and initial item pool. Thematic analysis of transcripts from cognitive debriefing interviews and online clinician surveys established content validity. Consensus discussions with the patient and public involvement group of the Therapies for Long COVID in non-hospitalised individuals: From symptoms, patient reported outcomes and immunology to targeted therapies (TLC Study) confirmed face validity. Rasch analysis of field test data guided item and scale refinement and provided initial evidence of the SBQ-LC's measurement properties.

resultsSBQ-LC (version 1.0) is a modular instrument measuring patient reported outcomes and is composed of 17 independent scales with promising psychometric properties. Respondents rate their symptom burden during the past seven days using a dichotomous response or 4 point rating scale. Each scale provides coverage of a different symptom domain and returns a summed raw score that can be transformed to a linear (0-100) score. Higher scores represent higher symptom burden. After rating scale refinement and item reduction, all scales satisfied the Rasch model requirements for unidimensionality (principal component analysis of residuals: first residual contrast values <2.00 eigenvalue units) and item fit (outfit mean square values within 0.5 -1.5 logits). Rating scale categories were ordered with acceptable category fit statistics (outfit mean square values <2.0 logits). 14 item pairs had evidence of local dependency (residual correlation values >0.4). Across the 17 scales, person reliability ranged from 0.34 to 0.87, person separation ranged from 0.71 to 2.56, item separation ranged from 1.34 to 13.86, and internal consistency reliability (Cronbach's alpha) ranged from 0.56 to 0.91.

conclusionsSBQ-LC (version 1.0) is a comprehensive patient reported outcome instrument developed using modern psychometric methods. It measures symptoms of long covid important to people with lived experience of the condition and may be used to evaluate the impact of interventions and inform best practice in clinical management.

Indexed as

COVID-19AdolescentAdultHumansPost-Acute COVID-19 SyndromeProspective StudiesReproducibility of ResultsSurveys and Questionnaires

Identifiers

PMID35477524
PMCPMC9043395
OpenAlexW4225145806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.